keyboard_arrow_right
Search keyboard_arrow_right
keyboard_arrow_left Hide
Day Two, Wednesday, April 17th - ET (Eastern Time, GMT-05:00)
search
Day Two, Wednesday, April 17th - ET (Eastern Time, GMT-05:00)
search
7:30am - 8:00am
Continental Breakfast
8:00am - 8:15amLIVE STREAM
Chairperson's Review of Day One
- John Oroho - President and General Manager, RLDatix Life Sciences
8:15am - 9:00amLIVE STREAM
Former Prosecutor Debrief—Hear an In-Depth Assessment and Forecast of Enforcement Activity Impacting the Life Sciences Marketplace
- Tom Gregory - Partner, EY
- George Karavetsos - White Collar Defense, Compliance, and Investigations Practice Group Leader, Buchanan Ingersoll & Rooney PC
- George Varghese - Partner, WilmerHale LLP
- Jane Yoon - Partner, Litigation Department, Paul Hastings
9:00am - 10:00amLIVE STREAM
Industry Pioneer Panel—A Look at the Rapid Adoption of AI Across the Life Sciences Sector
Hear from tech trailblazers as they discuss the application of AI across all facets of the business (research, development manufacturing, marketing, etc.), and the need for compliance programs to create and implement appropriate risk mitigation strategies and ensure that the adoption across their companies is done responsibly.
- Katie Jacyna - Vice President, Product Development, Helio
- John Poulin - Chief Technology Officer and Partner, Helio
- Lucy Muzzy - Vice President & Lead Counsel, Compliance, Artificial Intelligence; Digital Health & Medicines; M&A/Business Development, Pfizer
- Daryl Kreml - Senior Vice President, Chief Enterprise Risk and Compliance Officer, Sage Therapeutics
- Sheea Sybblis - VP, Human Pharma Business Law, Boehringer Ingelheim
10:00am - 10:30am
Networking and Refreshment Break
10:30am - 11:30amLIVE STREAM
CCO and GC Luminary Series—A Showcase of Innovators Sharing Insights on Advancements and Key Areas of Focus for 2024
- Jeff Rosenbaum - Co-Founder and Partner, Dovetail Consulting Group
- Neil Falkingham - Senior Vice President, Chief Compliance Officer, GSK
- Shefali Kothari - Chief Compliance Officer, US and Country Head, Ethics Risk and Compliance, Novartis
- Isabel Duffy - Senior Vice President, Chief Ethics and Compliance Officer, Merck
- Betania Glorio - Chief Compliance Officer and Head of Group Compliance and Data Privacy, EMD Serono
11:30am - 12:30pmLIVE STREAM
Global CCO Spotlight— An International Dialogue and Discussion on Compliance and Risk
- Joy Dowdle - Partner, Life Sciences & Healthcare Practice, Paul Hastings
- Jennifer McGee - Senior Vice President, Global Chief Ethics and Compliance Officer, Otsuka Pharmaceutical Companies
- Sarah Whipple - Vice President, Global Chief Compliance Officer, Apellis Pharmaceuticals
- Kelley Medeiros - Compliance Officer, Global & US Oncology, EMD Serono
12:30pm - 1:30pm
Networking Luncheon
Innovation Incubator This new, interactive format is designed to ignite fresh ideas and drive industry collaboration.
Showing 4 of 4 Streams
Compliant Application of AI and Machine Learning within Life Sciences
Building a Compliance Program—Emerging/Small Company Perspective
From Design to Delivery — An Interactive Workshop on Planning Risk Assessments
Establish Benchmarks and Best Practices for Speaker Programs, HCP Engagement and FMV Contracting
1:30pm - 3:00pm
Artificial Intelligence in Life Sciences Compliance
- Neeraj Gupta - Managing Partner, Cresen Solutions
- Asha Green - Global Head, I&C Risk Assessment and Mitigation Planning & Senior Business Function Advisor, Indivior
- Erin Vales - I&C Global Data Analytics Lead, Indivior
- Awet Gerbrehiwet-Wilder - US Head of Auditing and Monitoring, Integrity & Compliance, Indivior
1:30pm - 3:00pm
Building a Compliance Program—Emerging/Small Company Perspective
- Tim Moore - Vice President, Head of Commercial Legal & Compliance, Corium
- Amy Yuda - Associate Director, Compliance, Covis Pharma Group
- Jim Dawson - Vice President, Compliance Solutions, qordata
- Rujul Desai - Partner, Covington & Burling LLP
1:30pm - 3:00pm
From Design to Delivery — An Interactive Workshop on Planning Risk Assessments
- David Ryan - Vice President, Legal, and Chief Compliance Officer, Ardelyx, Inc
- Jonathan Wilkenfeld - President, Potomac River Partners
1:30pm - 3:00pm
Establish Benchmarks and Best Practices for Speaker Programs, HCP Engagement and FMV Contracting
- Brian P. Sharkey - Head of North America Compliance & Ethics, Teva Pharmaceuticals
- Jean McKiernan - Partner, Dovetail Consulting Group
- Cindy Cetani - Chief Integrity & Compliance Officer, Indivior
- John Kelly - Partner and Chair, Healthcare Department and Industry Practice, Barnes & Thornburg, LLP (Washington, D.C.)
3:00pm - 3:30pm
Networking and Refreshment Break
Showing 4 of 4 Streams
Compliance Playbook—Leveraging Omnichannel Strategies and Digital Tools to Enhance HCP and Patient Engagement
Compliance Guide for Ensuring Compliant Patient Support and Assistance Programs
Strategies to Advance Auditing and Monitoring Programs
Medical and Commercial Continuum—Updated Frameworks for Collaboration and Communication
3:30pm - 5:00pm
Compliance Playbook—Leveraging Omnichannel Strategies and Digital Tools to Enhance HCP and Patient Engagement
- William Weisiger - Global Omnichannel Strategy and Operations, Eli Lilly and Company
- Julie DeLong, CFA - Senior Managing Director, Ankura
- Joseph DiGiacomo - Healthcare Compliance Officer, Innovative Medicine - Oncology, Johnson & Johnson
3:30pm - 5:00pm
Compliance Guide for Ensuring Compliant Patient Support and Assistance Programs
- Nicole Palmquist - Director, IM US ERC Advisor – Novartis Patient Support and NPAF, Novartis
- Peter Agnoletto - Compliance Officer General Medicines and Consumer Healthcare, NA Ethics & Business Integrity, Sanofi US
- Kathy Durousseau - Legal & Compliance Consultant, SCILEX Holding Company
- Jane Yoon - Partner, Litigation Department, Paul Hastings
3:30pm - 5:00pm
Strategies to Advance Auditing and Monitoring Programs
- Jack Tanselle - Managing Director, Deloitte
- Marcus Green - Vice President, Risk Analytics and Monitoring, GSK
- Colleen Doyle - Senior Director, Compliance & Risk Insights, Sage Therapeutics
- Vanessa Gaynor - Associate Director- Innovation, Digital Enablement, and Analytic Solutions, Merck
3:30pm - 5:00pm
Medical and Commercial Continuum—Updated Frameworks for Collaboration and Communication
- Sarah Whipple - Vice President, Global Chief Compliance Officer, Apellis Pharmaceuticals
- Patricia Cone - Director, Compliance, Boehringer Ingelheim USA Corporation
- Kari Loeser - Vice President & Chief Compliance Officer, Cytokinetics
- Steve Vincze - Founder/President & CEO, TRESTLE Compliance, LLC.
5:00pm - 5:05pm
Close of Day Two